X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Procter & Gamble Health Ltd.
BSE CODE: 500126   |   NSE CODE: PGHL   |   ISIN CODE : INE199A01012   |   14-Aug-2025 Hrs IST
BSE NSE
Rs. 6287.40
106.7 ( 1.73% )
 
Prev Close ( Rs.)
6180.70
Open ( Rs.)
6197.00
 
High ( Rs.)
6365.10
Low ( Rs.)
6195.00
 
Volume
278
Week Avg.Volume
659
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 6295.00
112.5 ( 1.82% )
 
Prev Close ( Rs.)
6182.50
Open ( Rs.)
6182.50
 
High ( Rs.)
6374.00
Low ( Rs.)
6182.50
 
Volume
9812
Week Avg.Volume
12879
 
52 WK High-Low Range(Rs.)
4863
6500
Particulars Mar 2025Jun 2024Mar 2024Jun 2023Jun 2022
Operational & Financial Ratios          
   Earnings Per Share (Rs)141.21  121.07  121.07  138.23  115.98  
   CEPS(Rs)151.27  137.58  137.58  155.16  132.29  
   DPS(Rs)125.00  260.00  260.00  95.00  52.50  
   Book NAV/Share(Rs)320.52  319.10  319.10  447.62  366.99  
   Tax Rate(%)24.78  26.47  26.47  26.97  24.02  
Margin Ratios          
   Core EBITDA Margin(%)30.94  24.30  24.30  24.44  22.73  
   EBIT Margin(%)30.32  21.76  21.76  23.71  21.55  
   Pre Tax Margin(%)30.28  21.71  21.71  23.66  21.51  
   PAT Margin (%)22.78  15.96  15.96  17.28  16.35  
   Cash Profit Margin (%)24.40  18.14  18.14  19.39  18.64  
Performance Ratios          
   ROA(%)16.97  9.49  13.43  11.00  9.83  
   ROE(%)44.15  31.58  31.58  33.94  29.41  
   ROCE(%)58.05  42.52  42.52  46.07  38.45  
   Asset Turnover(x)0.74  0.59  0.84  0.64  0.60  
   Sales/Fixed Asset(x)4.62  5.18  5.18  5.27  5.17  
   Working Capital/Sales(x)3.31  4.12  4.12  2.70  3.13  
Efficiency Ratios          
   Fixed Capital/Sales(x)0.22  0.19  0.19  0.19  0.19  
   Receivable days40.92  29.14  29.14  27.36  22.20  
   Inventory Days38.75  35.37  35.37  34.37  36.19  
   Payable days235.41  223.07  223.07  206.35  188.51  
Valuation Parameters          
   PER(x)36.42  41.71  38.87  37.97  36.10  
   PCE(x)34.00  36.71  34.21  33.83  31.65  
   Price/Book(x)16.04  15.83  14.75  11.73  11.41  
   Yield(%)2.43  5.15  5.52  1.81  1.25  
   EV/Net Sales(x)8.94  7.07  6.57  6.73  5.95  
   EV/Core EBITDA(x)25.39  25.30  23.53  24.12  23.59  
   EV/EBIT(x)26.75  29.70  27.62  26.27  26.11  
   EV/CE(x)15.55  15.12  14.06  11.02  3.42  
   M Cap / Sales9.14  7.28  6.79  7.09  6.24  
Growth Ratio          
   Net Sales Growth(%)-18.86  -6.37  -6.37  10.34  10.48  
   Core EBITDA Growth(%)2.21  -6.25  -6.25  22.15  6.34  
   EBIT Growth(%)13.87  -12.99  -12.99  24.11  8.42  
   PAT Growth(%)16.63  -12.42  -12.42  19.19  8.89  
   EPS Growth(%)16.63  -12.42  -12.42  19.19  8.89  
Financial Stability Ratios          
   Total Debt/Equity(x)0.00  0.00  0.00  0.00  0.00  
   Current Ratio(x)2.44  1.49  2.39  1.72  1.62  
   Quick Ratio(x)1.94  1.31  1.90  1.53  1.43  
   Interest Cover(x)725.70  380.61  380.61  409.05  604.26  
   Total Debt/Mcap(x)0.00  0.00  0.00  0.00  0.00